Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to Assess the impact of HIV on the life course of patients aged 60 and over.


Clinical Trial Description

COREVIH IDF Nord and CERMES3 conducted a first qualitative survey of 32 HIV patients aged 60 and over. The study, in the form of an individual interview, aimed to identify the difficulties that PLWHIV may encounter in their life course, to question their future and the impact that HIV could have. From this study, a questionnaire was drawn up covering the points raised by the qualitative study. The questionnaire was designed by doctors of the four hospitals that participated in the first study and a sociologist from CERMES3. After patient's oral agreement obtained, the study questionnaire "Sociological study PVHIV ≥ 60 years" will be given to the patient for completion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05083273
Study type Observational
Source Centre Hospitalier René Dubos
Contact
Status Completed
Phase
Start date May 18, 2021
Completion date June 24, 2021

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04575545 - Prevalence of COVID-19 Infection in a Cohort of Patients Infected by the HIV and Patients Taking PrEP
Completed NCT03195452 - QDISS Stud: QD Isentress as Switch Strategy in Virologically Suppressed HIV-1 Infected-Patient Phase 2
Active, not recruiting NCT04581746 - Impact of the Epidemic of COVID-19 Infection Among People Living With HIV (SARS-CoV-2) N/A
Not yet recruiting NCT05322083 - HIV A6 Genome In ART Unsuccessful Patients On DOR
Completed NCT04772469 - Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men N/A
Terminated NCT02898896 - Coronary Artery Disease (CAD) in Suppressed HIV-infected N/A
Completed NCT03671291 - Missed Opportunities to Pre-exposure Prophylaxis for HIV Infection on Person Newly Diagnosed With HIV N/A